tremelimumab-actl 25 MG in 1.25 ML Injection

RxCUI: 2619325
RxNorm name: tremelimumab-actl 25 MG in 1.25 ML Injection
Display name: tremelimumab-actl 25 MG in 1.25 ML Injection
Full name: tremelimumab-actl 25 MG in 1.25 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761289	Imjudo	tremelimumab-actl	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
IMJUDO	TREMELIMUMAB	AstraZeneca Pharmaceuticals LP	6690679c-be2f-4588-a2e4-89fff74dd6be	2024-07-24	Warnings, Adverse reactions	Exact identifier rxcui: 2619325

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6690679c-be2f-4588-a2e4-89fff74dd6be	tremelimumab-actl 25 MG in 1.25 ML Injection [PSN] · 1.25 ML tremelimumab-actl 20 MG/ML Injection [SCD] · tremelimumab-actl 20 MG/ML per 1.25 ML Injection [SY] · tremelimumab-actl 25 MG per 1.25 ML Injection [SY]	4	14	These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 2022	20240724